REPORT: Department of Ophthalmology, Ospedale San Rafaelle, Milan, Italy
Intravitreal injections during COVID-19 pandemic outbreak: the experience of a tertiary eye care referral center in Italy
Three levels of organizational hierarchy were adopted.
First, patients were screened by telephone for: (i) complaints of fever or upper respiratory symptoms; and (ii) contact with suspected or confirmed cases of COVID-19. Patients who fulfilled any of these criteria were recontacted after 14 days.
Second, patients not fulfilling any of the above criteria were managed as follows:
– AMD patients were kept treating with a treat-and-extend/proactive protocol.
– Myopic patients with neovascularization were asked for complains of reduced visual acuity or increase/appearance of other visual symptoms (e.g. metamorphopsia). Cases with stable symptoms were recontacted after 14 days.
– Diabetic and RVO patients with visual symptoms suggesting the development of macular edema were asked to attend the visit and eventually underwent intravitreal therapy.
Patients requiring intravitreal treatment were asked to attend the clinic with no more than one accompanying person. Moreover, they were asked to wear surgical masks.
Third, healthcare personnel were appropriately equipped with visors or protective eyewear, gloves, and surgical masks during intravitreal procedures.